My cold has improved, and I now have an appointment at Dana Farber for this Friday. Hopefully, my neutrophils will have recovered enough for me to be able to resume my treatment this week.
The Cycle 5 results have come back. My light-chain ratio is still in the normal range, which is great! In fact, over the last three cycles, it has been moving steadily towards the middle of the normal range, which I find comforting.
The monoclonal protein study of my 24-hour urine sample came back as "No monoclonal protein detected", which is also great news! This result has been consistently negative ever since I began the Clinical Trial. I'm glad I remembered to take in the 24-hour urine sample this cycle.
The serum protein electrophoresis result, on the other hand, shows a gamma M-spike of 0.13. That is up slightly from the 0.12 from the last cycle and 0.10 from the one before that.
While it is a bit disconcerting to see this number go up, the medical interpretation is the same as it has been for the last three cycles: "Patient's faint IgG Kappa is most likely associated with Daratumumab therapy".
All in all, I am quite pleased with these results. Clearly, I am responding to this treatment regimen. I am so glad I managed to squeak in on this Clinical Trial.
No comments:
Post a Comment